EmStop announced today that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and performance of the EPS, an investigational device for cerebral embolic protection designed to capture and remove debris that includes thrombus during commercially … [Read more...] about EmStop initiates IDE study of novel embolic protection device
